Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: A meta-analysis.

about

Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: A meta-analysis.

Item

http://www.wikidata.org/entity/Q49309172

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@en

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@nl

type

Item

label

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@en

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@nl

prefLabel

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@en

Prognostic significance of cir ...... solid tumors: A meta-analysis.

@nl

P1476

Prognostic significance of cir ...... solid tumors: A meta-analysis

@en

P2093

Bin Xu

http://www.w3.org/2001/XMLSchema#string

Changping Wu

http://www.w3.org/2001/XMLSchema#string

Chen Wu

http://www.w3.org/2001/XMLSchema#string

Jingting Jiang

http://www.w3.org/2001/XMLSchema#string

Wei Wei

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Immune Checkpoint Blockade in Cancer Therapy

Immune checkpoint blockade: a common denominator approach to cancer therapy

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Practical methods for incorporating summary time-to-event data into meta-analysis

Alternative splice variants of the human PD-1 gene

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

The journey from discoveries in fundamental immunology to cancer immunotherapy.

PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis.

P304

e9617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000009617

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29504990

http://www.w3.org/2001/XMLSchema#string

P932

5779759

http://www.w3.org/2001/XMLSchema#string